L-Arginine Pathway

Women maintain the L-Arginine NO pathway slightly longer than men, but it still declines with aging. High-dose L-arginine supplementation is presented as counterproductive for cardiovascular or sexual health in midlife and beyond. L-Arginine, L-Citrulline, and related supplements do not overcome NOS enzymatic impairment after age 40. Genetic variation may influence nitric oxide synthase function, but the article does not provide genotype-specific protocols. Nitric oxide synthase converts L-arginine to nitric oxide. The L-Arginine pathway converts L-Arginine and oxygen into nitric oxide via the NOS enzyme within blood vessel endothelium. The L-arginine pathway converts L-arginine into nitric oxide inside endothelial cells using eNOS and multiple co-factors. Endothelial nitric oxide synthase is presented as the vascularly beneficial nitric oxide pathway. Reduced BH4 cofactor availability impairs NOS function, diverting it toward reactive oxygen species production instead of nitric oxide. Inducible nitric oxide synthase is associated with immune and inflammatory responses and can dominate during infection or chronic inflammation. Inflammation may impair vascular function by shifting…